Clinical Trials Directory

Trials / Completed

CompletedNCT00345046

A Comparison of Three Different Formulations of Prednisolone Acetate 1%

A Comparison of Three Different Formulations of Topical Prednisolone Acetate 1% for Control of Post Glaucoma and/or Cataract Surgery Inflammation.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Indiana University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.

Detailed description

Overall Study Design: Structure: This is a randomized, double-masked prospective study. The study medications will be masked and randomized by the outpatient pharmacy at Indiana University Hospital. Duration: Treatment duration: The duration of each subject's participation will be for up to 2 months after surgery. One hundred and two subjects will be enrolled over a twelve-month time span. Controls: Examiner, staff, and subjects are masked. Parallel group comparison. Dosage/Dose Regimen/Instructions: Subjects scheduled for glaucoma and/or cataract surgery will be recruited. Subjects may not be currently on any steroid or ophthalmic non-steroidal anti-inflammatory (NSAID) therapy for a minimum of 6 weeks prior to surgery. Subjects will be randomized to receive a dose of Pred Forte 1% (Allergan), Econopred Plus 1% (Alcon) or prednisolone acetate 1% (Falcon) four times a day starting immediately after finishing the surgery for two weeks, then twice a day for two more weeks. After 1 month of therapy subjects will stop or continue steroid treatment based on clinical findings. No other subconjunctival steroid or ointment will be used intra-operatively or post-operatively. The eye drop will be instilled per labeling instructions.

Conditions

Interventions

TypeNameDescription
DRUGPred ForteFour drops daily decreasing to once daily over four weeks.
DRUGEconoPred PlusPrednisolone Acetate four times daily decreasing to once daily over four weeks.
DRUGPrednisolone AcetateDosed four times daily decreasing to once daily over four weeks.

Timeline

Start date
2002-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2006-06-27
Last updated
2015-06-03
Results posted
2014-04-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00345046. Inclusion in this directory is not an endorsement.